Acorda Therapeutics, Inc. Skyrocketed
Fri, Sep 25, 2020 at 05:30 PM
Acorda Therapeutics, Inc. (ACOR:NASDAQ) soared at $0.62, representing a gain of 30.1%. The stock got featured on our News Catalysts scanner on Thu 17 Sep 20 at 07:55 AM in the 'INVESTOR UPDATE' category. From Thu 10 Sep 20, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Thu 17 Sep 20 at $0.62 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About Acorda Therapeutics, Inc. (ACOR:NASDAQ)
Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.
Top 10 Gainers:
- CBAK Energy Technology, Inc. (CBAT:NASDAQ), 81.48%
- Urban One, Inc. (UONE:NASDAQ), 71.28%
- Sky Solar Holdings, Ltd. (SKYS:NASDAQ), 50.3%
- Professional Diversity Network, Inc. (IPDN:NASDAQ), 49.4%
- TAT Technologies Ltd. (TATT:NASDAQ), 45.5%
- Broadway Financial Corporation (BYFC:NASDAQ), 44.44%
- SG Blocks, Inc. (SGBX:NASDAQ), 42.76%
- Sypris Solutions, Inc. (SYPR:NASDAQ), 39.36%
- Infrastructure and Energy Alternatives, Inc. (IEA:NASDAQ), 33.59%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 30.13%